Loading...

Femasys Inc.

FEMYNASDAQ
Healthcare
Medical - Instruments & Supplies
$0.36
$-0.00(-1.16%)
U.S. Market opens in 13h 45m

Femasys Inc. Fundamental Analysis

Femasys Inc. (FEMY) shows moderate financial fundamentals with a PE ratio of -1.95, profit margin of -5.22%, and ROE of -2.58%. The company generates $0.0B in annual revenue with strong year-over-year growth of 40.77%.

Key Strengths

Cash Position22.54%
PEG Ratio-0.02
Current Ratio3.91

Areas of Concern

ROE-2.58%
Operating Margin-6.88%
We analyze FEMY's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -606.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-606.3/100

We analyze FEMY's fundamental strength across five key dimensions:

Efficiency Score

Weak

FEMY struggles to generate sufficient returns from assets.

ROA > 10%
-75.19%

Valuation Score

Excellent

FEMY trades at attractive valuation levels.

PE < 25
-1.95
PEG Ratio < 2
-0.02

Growth Score

Excellent

FEMY delivers strong and consistent growth momentum.

Revenue Growth > 5%
40.77%
EPS Growth > 10%
44.05%

Financial Health Score

Excellent

FEMY maintains a strong and stable balance sheet.

Debt/Equity < 1
0.65
Current Ratio > 1
3.91

Profitability Score

Weak

FEMY struggles to sustain strong margins.

ROE > 15%
-258.08%
Net Margin ≥ 15%
-5.22%
Positive Free Cash Flow
No

Key Financial Metrics

Is FEMY Expensive or Cheap?

P/E Ratio

FEMY trades at -1.95 times earnings. This suggests potential undervaluation.

-1.95

PEG Ratio

When adjusting for growth, FEMY's PEG of -0.02 indicates potential undervaluation.

-0.02

Price to Book

The market values Femasys Inc. at 3.33 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

3.33

EV/EBITDA

Enterprise value stands at -0.77 times EBITDA. This is generally considered low.

-0.77

How Well Does FEMY Make Money?

Net Profit Margin

For every $100 in sales, Femasys Inc. keeps $-5.22 as profit after all expenses.

-5.22%

Operating Margin

Core operations generate -6.88 in profit for every $100 in revenue, before interest and taxes.

-6.88%

ROE

Management delivers $-2.58 in profit for every $100 of shareholder equity.

-2.58%

ROA

Femasys Inc. generates $-75.19 in profit for every $100 in assets, demonstrating efficient asset deployment.

-75.19%

Following the Money - Real Cash Generation

Operating Cash Flow

Femasys Inc. generates limited operating cash flow of $-7.98M, signaling weaker underlying cash strength.

$-7.98M

Free Cash Flow

Femasys Inc. generates weak or negative free cash flow of $-8.21M, restricting financial flexibility.

$-8.21M

FCF Per Share

Each share generates $-0.28 in free cash annually.

$-0.28

FCF Yield

FEMY converts -1.75% of its market value into free cash.

-1.75%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-1.95

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.02

vs 25 benchmark

P/B Ratio

Price to book value ratio

3.33

vs 25 benchmark

P/S Ratio

Price to sales ratio

4.51

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.65

vs 25 benchmark

Current Ratio

Current assets to current liabilities

3.91

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-2.58

vs 25 benchmark

ROA

Return on assets percentage

-0.75

vs 25 benchmark

ROCE

Return on capital employed

-1.23

vs 25 benchmark

How FEMY Stacks Against Its Sector Peers

MetricFEMY ValueSector AveragePerformance
P/E Ratio-1.9528.65 Better (Cheaper)
ROE-258.08%795.00% Weak
Net Margin-521.78%-49787.00% (disorted) Weak
Debt/Equity0.650.40 Weak (High Leverage)
Current Ratio3.913.73 Strong Liquidity
ROA-75.19%-20255.00% (disorted) Weak

FEMY outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Femasys Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-34.29%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

19.89%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

-12.68%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ